Yaniv Linde in his lab. Millions of people the world over suffer today from obesity, yet there is no “magic bullet” that has yet provided a universally accepted solution. However, a young researcher at the Hebrew University of Jerusalem feels he has come up with a practical weight loss solution for the obese person without his having to feel hungry.
For this development, Yaniv Linde, a 32-year-old Ph.D. student of Prof. Chaim Gilon in the Department of Organic Chemistry at the Hebrew University, has been named a first place winner of a Kaye Innovation Award, which was presented today (June 6) during the 70th meeting of the Hebrew University Board of Governors.
Linde and his associates have developed a compound that mimics the activity of the naturally occurring hormone called aMSH. This hormone is naturally excreted during eating and binds to a receptor in the brain called MC4R. When this “communication” occurs on a substantial level, the brain sends out a signal that one feels “full.”
The young Hebrew university researchers developed a novel method for synthesizing a peptide (a peptide is a compound linking two or more amino acids) which can serve as an analog to the naturally occurring aMSH hormone. They were able to demonstrate that their peptide, which they call BL-3020, displayed good metabolic stability to intestinal enzymes when swallowed, and that it was able to cross the intestinal wall and gain access into the blood stream. Once in the blood, it could make its way to the MC4R receptor and “close the circuit” to send out the “full” signal.
The result is that a person seriously wishing to overcome obesity could take this compound orally in order to curb his appetite, thus leading to natural weight loss. In experiments with mice, it was shown that a single oral administration of BL-3020 led to reduced consumption over a period of 24 hours. Over a 12-day p eriod of daily dosages, the mice weighed 40 percent less than the average for mice of their size and age who were not being given the compound.
The peptide has been patented in Europe and the U.S., and a commercial firm, Bioline RX Ltd. Of Jerusalem has purchased development rights from Yissum, the Hebrew University’s technology transfer company, and is currently working towards creating a commercial anti-obesity drug.
Source:The Hebrew University of Jerusalem
Related biology news :
1. Research may provide new link between soft drinks and weight gain
2. Eating, body weight regulated by specific neurons
3. An essential regulator of body weight revealed
4. Engineers discover why toucan beaks are models of lightweight strength
5. Its not fair! We are programmed to resist weight loss
6. Just like us, social stress prompts hamsters to overeat, gain weight
7. Very low birth weight linked to reduced quality of life in pre-school children
8. 76 percent of workers older than 60 years of age are overweight or obese
9. Brown seaweed contains promising fat fighter, weight reducer
10. Underweight women at greater risk of miscarriage
11. Scripps research team discovers a chemical pathway that causes mice to overeat and gain weight